Literature DB >> 2663993

Genomic structure of the human monocyte-derived neutrophil chemotactic factor IL-8.

N Mukaida1, M Shiroo, K Matsushima.   

Abstract

To identify possible regulatory sites of the gene expression, we cloned the genomic DNA of human monocyte-derived neutrophil chemotactic factor (MDNCF/IL-8), whose mRNA is induced by IL-1 or TNF and determined its entire nucleotide sequence. The results show that the MDNCF/IL-8 gene consists of 4 exons and 3 introns with a single "CAT"- and "TATA"-like structure. The 5'-flanking region of MDNCF/IL-8 gene shows no overall sequence similarity with that of other cytokine and acute phase reactant genes whose production is also affected by IL-1 and TNF. The 5' flanking region, however, contains potential binding sites for several nuclear factors including activation factor-1, activation factor-2, IFN regulatory factor-1, and hepatocyte nuclear factor-1. In addition, the glucocorticoid responsive element and heat shock element were located in the 5'-flanking region. Inasmuch as PMA induces MDNCF/IL-8 mRNA accumulation in human PBMC and a glucocorticoid inhibits the induction of MDNCF/IL-8 mRNA by LPS, the expression of this gene is probably regulated by interaction of these nuclear factors with the 5'-flanking DNA.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2663993

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  117 in total

Review 1.  Cytokines in asthma.

Authors:  K F Chung; P J Barnes
Journal:  Thorax       Date:  1999-09       Impact factor: 9.139

2.  Eosinophil granule-derived major basic protein induces IL-8 expression in human intestinal myofibroblasts.

Authors:  G T Furuta; S J Ackerman; J Varga; A M Spiess; M Y Wang; B K Wershil
Journal:  Clin Exp Immunol       Date:  2000-10       Impact factor: 4.330

3.  Autoregulatory effect of interleukin-10 on proinflammatory cytokine production by Porphyromonas gingivalis lipopolysaccharide-tolerant human monocytes.

Authors:  H Shimauchi; T Ogawa; K Okuda; Y Kusumoto; H Okada
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

4.  Lack of association of interleukin-6 and interleukin-8 gene polymorphisms in Chinese patients with systemic lupus erythematosus.

Authors:  Chung-Ming Huang; An-Ping Huo; Chang-Hai Tsai; Chi-Lan Chen; Fuu-Jen Tsai
Journal:  J Clin Lab Anal       Date:  2006       Impact factor: 2.352

5.  The 3'-untranslated region of human interleukin-8 mRNA suppresses IL-8 gene expression.

Authors:  Y Yu; K Chadee
Journal:  Immunology       Date:  2001-04       Impact factor: 7.397

6.  Novel Innate Immune Genes Regulating the Macrophage Response to Gram Positive Bacteria.

Authors:  Scott Alper; Laura A Warg; Lesly De Arras; Brenna R Flatley; Elizabeth J Davidson; Jenni Adams; Keith Smith; Christine L Wohlford-Lenane; Paul B McCray; Brent S Pedersen; David A Schwartz; Ivana V Yang
Journal:  Genetics       Date:  2016-06-29       Impact factor: 4.562

7.  Regulation of deoxycholate induction of CXCL8 by the adenomatous polyposis coli gene in colorectal cancer.

Authors:  Nathaniel S Rial; Gwendal Lazennec; Anil R Prasad; Robert S Krouse; Peter Lance; Eugene W Gerner
Journal:  Int J Cancer       Date:  2009-05-15       Impact factor: 7.396

8.  Transcriptional inhibition of the interleukin-8 gene by interferon is mediated by the NF-kappa B site.

Authors:  I C Oliveira; N Mukaida; K Matsushima; J Vilcek
Journal:  Mol Cell Biol       Date:  1994-08       Impact factor: 4.272

9.  Lipopolysaccharide induction of tissue factor gene expression in monocytic cells is mediated by binding of c-Rel/p65 heterodimers to a kappa B-like site.

Authors:  P A Oeth; G C Parry; C Kunsch; P Nantermet; C A Rosen; N Mackman
Journal:  Mol Cell Biol       Date:  1994-06       Impact factor: 4.272

10.  Association between interleukin 8 -251 A/T and +781 C/T polymorphisms and osteosarcoma risk in Chinese population: a case-control study.

Authors:  Yang Chen; Yang Yang; Song Liu; Shaowen Zhu; Hongfeng Jiang; Jinmin Ding
Journal:  Tumour Biol       Date:  2015-11-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.